Annual Total Liabilities
$6.75 M
-$4.05 M-37.53%
December 31, 2023
Summary
- As of February 8, 2025, ENLV annual total liabilities is $6.75 million, with the most recent change of -$4.05 million (-37.53%) on December 31, 2023.
- During the last 3 years, ENLV annual total liabilities has risen by +$1.88 million (+38.51%).
- ENLV annual total liabilities is now -37.53% below its all-time high of $10.80 million, reached on December 31, 2022.
Performance
ENLV Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$3.21 M
-$130.00 K-3.89%
September 30, 2024
Summary
- As of February 8, 2025, ENLV quarterly total liabilities is $3.21 million, with the most recent change of -$130.00 thousand (-3.89%) on September 30, 2024.
- Over the past year, ENLV quarterly total liabilities has dropped by -$4.95 million (-60.65%).
- ENLV quarterly total liabilities is now -70.74% below its all-time high of $10.97 million, reached on March 31, 2022.
Performance
ENLV Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
ENLV Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -37.5% | -60.6% |
| 3 y3 years | +38.5% | -66.0% |
| 5 y5 years | +408.1% | -66.0% |
ENLV Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -37.5% | at low | -70.7% | at low |
| 5 y | 5-year | -37.5% | +38.5% | -70.7% | at low |
| alltime | all time | -37.5% | +8229.6% | -70.7% | +2350.4% |
Enlivex Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $3.21 M(-3.9%) |
| Jun 2024 | - | $3.34 M(-20.4%) |
| Mar 2024 | - | $4.20 M(-37.8%) |
| Dec 2023 | $6.75 M(-37.5%) | $6.75 M(-17.3%) |
| Sep 2023 | - | $8.16 M(-6.2%) |
| Jun 2023 | - | $8.69 M(-8.0%) |
| Mar 2023 | - | $9.45 M(-12.5%) |
| Dec 2022 | $10.80 M(+6.9%) | $10.80 M(+18.2%) |
| Sep 2022 | - | $9.14 M(+3.2%) |
| Jun 2022 | - | $8.86 M(-19.3%) |
| Mar 2022 | - | $10.97 M(+8.5%) |
| Dec 2021 | $10.11 M(+107.5%) | $10.11 M(+0.2%) |
| Sep 2021 | - | $10.08 M(+102.4%) |
| Jun 2021 | - | $4.98 M(-7.0%) |
| Mar 2021 | - | $5.36 M(+10.0%) |
| Dec 2020 | $4.87 M(-22.4%) | $4.87 M(-0.0%) |
| Sep 2020 | - | $4.87 M(-7.1%) |
| Jun 2020 | - | $5.25 M(-6.2%) |
| Mar 2020 | - | $5.59 M(-10.9%) |
| Dec 2019 | $6.28 M | $6.28 M(+15.5%) |
| Sep 2019 | - | $5.43 M(-0.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $5.47 M(-2.2%) |
| Mar 2019 | - | $5.59 M(+320.9%) |
| Dec 2018 | $1.33 M(+188.7%) | $1.33 M(+822.2%) |
| Jun 2018 | - | $144.00 K(-68.7%) |
| Dec 2017 | $460.00 K(-76.2%) | $460.00 K(-14.3%) |
| Sep 2017 | - | $537.00 K(-32.2%) |
| Jun 2017 | - | $792.00 K(-51.1%) |
| Mar 2017 | - | $1.62 M(-16.2%) |
| Dec 2016 | $1.93 M(-25.3%) | $1.93 M(-3.4%) |
| Sep 2016 | - | $2.00 M(+36.2%) |
| Jun 2016 | - | $1.47 M(-36.2%) |
| Mar 2016 | - | $2.30 M(-11.0%) |
| Dec 2015 | $2.58 M(+13.3%) | $2.58 M(+42.5%) |
| Sep 2015 | - | $1.81 M(+2.5%) |
| Jun 2015 | - | $1.77 M(+0.9%) |
| Mar 2015 | - | $1.75 M(-23.2%) |
| Dec 2014 | $2.28 M(+1640.5%) | $2.28 M(+99.0%) |
| Sep 2014 | - | $1.15 M(+60.3%) |
| Jun 2014 | - | $715.00 K(+445.8%) |
| Dec 2013 | $131.00 K(+61.7%) | $131.00 K |
| Dec 2012 | $81.00 K | - |
FAQ
- What is Enlivex Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Enlivex Therapeutics?
- What is Enlivex Therapeutics annual total liabilities year-on-year change?
- What is Enlivex Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Enlivex Therapeutics?
- What is Enlivex Therapeutics quarterly total liabilities year-on-year change?
What is Enlivex Therapeutics annual total liabilities?
The current annual total liabilities of ENLV is $6.75 M
What is the all time high annual total liabilities for Enlivex Therapeutics?
Enlivex Therapeutics all-time high annual total liabilities is $10.80 M
What is Enlivex Therapeutics annual total liabilities year-on-year change?
Over the past year, ENLV annual total liabilities has changed by -$4.05 M (-37.53%)
What is Enlivex Therapeutics quarterly total liabilities?
The current quarterly total liabilities of ENLV is $3.21 M
What is the all time high quarterly total liabilities for Enlivex Therapeutics?
Enlivex Therapeutics all-time high quarterly total liabilities is $10.97 M
What is Enlivex Therapeutics quarterly total liabilities year-on-year change?
Over the past year, ENLV quarterly total liabilities has changed by -$4.95 M (-60.65%)